CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I-II Study of Infusional Melphalan + Bortezomib for Myeloablative Therapy Prior to Autologous Transplant for Patients With Multiple Myeloma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02353572
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:44.533039+00:00
Published At: 2015-03-09T00:00:00+00:00
Record Updated At: 2015-03-09
Results Posted At: 2015-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Plasma Cell Myeloma", "Plasmacytosis", "Recurrent Plasma Cell Myeloma", "Smoldering Plasma Cell Myeloma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-03-09"
protocolSection.identificationModule.nctId: "NCT02353572"
protocolSection.identificationModule.officialTitle: "A Phase I-II Study of Infusional Melphalan + Bortezomib for Myeloablative Therapy Prior to Autologous Transplant for Patients With Multiple Myeloma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-03-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.